articleTop 1% cited
Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: A Gynecologic Oncology Group Study
Gynecologic Oncology · 2005 · Vol. 100(1) · pp. 27–32
Joan L. Walker✉(Oklahoma City University)Deborah K. Armstrong(Sidney Kimmel Cancer Center)Helen Huang(Gynecologic Oncology Group)Jeffrey Fowler(The Ohio State University)Kenneth Webster(Cleveland Clinic)Robert A. Burger(University of California, Irvine)Daniel L. Clarke‐Pearson(Duke University Hospital)
Ovarian cancer diagnosis and treatmentIntraperitoneal and Appendiceal MalignanciesEndometriosis Research and TreatmentMedicineGynecologic oncologyRegimenSurgeryChemotherapyHysterectomyOvarian cancerCatheterBowel resectionStage (stratigraphy)
MeSH terms
Antineoplastic Combined Chemotherapy ProtocolsCatheters, IndwellingCisplatinFemaleHumansInfusions, IntravenousInfusions, ParenteralNeoplasm StagingOvarian NeoplasmsTreatment OutcomePaclitaxel
Funding
- National Cancer Institute
Citations
322
FWCI
29.48
field-weighted impact
References
23
Percentile
100%
vs. same field & year
Citations per year
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.